valvookimakaj1362.blogspot.com
Liver toxicity is a main reason for regulatoryt agencies to deny approval for new drugs or take actioh againstexisting drugs. The researchers, who are workingt at the newly formed Institutee for DrugSafety Sciences, will use a virtual modelo of a liver to test how different druges may affect the organ. The research has the potential to speedf up the drug development andtestinf process. The Institute for Drug Safeth Sciences, which opened last week and featuresa 14,000-square-footg research laboratory, will work to studyh global drug safety It is being led by Paul Watkins, the Verned S. Caviness distinguished professor of medicineat UNC.
along with his scientist colleagues, will work with members of the biomedical and pharmaceutical the U.S. Food and Drug Administration and the Nationaol Institutes of Health to develop new drugsafet initiatives. The Institute for Drug Safethy Sciences was born from an agreement signes in April 2008 between UNC and Hamner to collaborate on researcnh intodrug safety, drug development and public It is located on Hamner’z campus in Research Triangle Park.
No comments:
Post a Comment